Cargando…

The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway

BACKGROUND: Accumulating evidence has revealed the pivotal role of epigenetic regulation in the pathogenesis of liver disease. However, the epigenetic mechanism that accounts for hepatic stellate cells (HSCs) activation in liver fibrosis remains largely unknown. METHODS: Primary HSCs were used to sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Fangyuan, Jiang, Shuheng, Li, Jun, Wang, Yahui, Zhu, Lili, Huang, Yiqin, Jiang, Xin, Hu, Xiaona, Zhou, Qi, Zhang, Zhigang, Bao, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354657/
https://www.ncbi.nlm.nih.gov/pubmed/30527625
http://dx.doi.org/10.1016/j.ebiom.2018.11.055
_version_ 1783391213065338880
author Dong, Fangyuan
Jiang, Shuheng
Li, Jun
Wang, Yahui
Zhu, Lili
Huang, Yiqin
Jiang, Xin
Hu, Xiaona
Zhou, Qi
Zhang, Zhigang
Bao, Zhijun
author_facet Dong, Fangyuan
Jiang, Shuheng
Li, Jun
Wang, Yahui
Zhu, Lili
Huang, Yiqin
Jiang, Xin
Hu, Xiaona
Zhou, Qi
Zhang, Zhigang
Bao, Zhijun
author_sort Dong, Fangyuan
collection PubMed
description BACKGROUND: Accumulating evidence has revealed the pivotal role of epigenetic regulation in the pathogenesis of liver disease. However, the epigenetic mechanism that accounts for hepatic stellate cells (HSCs) activation in liver fibrosis remains largely unknown. METHODS: Primary HSCs were used to screen the differentially expressed histone H3 lysine methyltransferases and demethylases during HSC activation. Loss-of-function experiments were applied to determine the cellular functions of KDM4D in HSCs. Transcriptome analysis was applied to explore the downstream targets of KDM4D. Real-time qPCR, western blotting, immunohistochemical staining, and chromatin immunoprecipitation were performed to uncover the underlying mechanism concerning KDM4D during liver fibrogenesis. FINDINGS: KDM4D was identified as a remarkable up-regulated histone H3 demethylase during HSC activation. The overexpression profile of KDM4D was confirmed in three fibrosis animal models and human fibrotic liver tissues. In vitro Kdm4d knockdown impaired the collagen gel contraction and migration capacity of primary HSCs. In established CCl(4)-induced mice model, Kdm4d knockdown inhibited fibrosis progression, and promoted fibrosis reversal, with enhanced thinning and splitting of fibrotic septa, as well as a dramatic decrease in collagen area. Whole gene transcriptome analysis showed the regulatory role of KDM4D in Toll-Like Receptor (TLR) signaling pathway. Mechanistically, KDM4D catalyzed histone 3 on lysine 9 (H3K9) di-, and tri-demethylation, which promoted TLR4 expression, and subsequently prompted liver fibrogenesis by activating NF-κB signaling pathways. INTERPRETATION: KDM4D facilitates TLR4 transcription through demethylation of H3K9, thus activating TLR4/NF-κB signaling pathways in HSCs, contributing to HSC activation and collagen crosslinking, further, hepatic fibrosis progression. FUND: Shanghai New Hundred Talents Program, Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program, Shanghai Key disciplines program of Health and Family Planning and Shanghai Sailing Program.
format Online
Article
Text
id pubmed-6354657
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63546572019-02-07 The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway Dong, Fangyuan Jiang, Shuheng Li, Jun Wang, Yahui Zhu, Lili Huang, Yiqin Jiang, Xin Hu, Xiaona Zhou, Qi Zhang, Zhigang Bao, Zhijun EBioMedicine Research paper BACKGROUND: Accumulating evidence has revealed the pivotal role of epigenetic regulation in the pathogenesis of liver disease. However, the epigenetic mechanism that accounts for hepatic stellate cells (HSCs) activation in liver fibrosis remains largely unknown. METHODS: Primary HSCs were used to screen the differentially expressed histone H3 lysine methyltransferases and demethylases during HSC activation. Loss-of-function experiments were applied to determine the cellular functions of KDM4D in HSCs. Transcriptome analysis was applied to explore the downstream targets of KDM4D. Real-time qPCR, western blotting, immunohistochemical staining, and chromatin immunoprecipitation were performed to uncover the underlying mechanism concerning KDM4D during liver fibrogenesis. FINDINGS: KDM4D was identified as a remarkable up-regulated histone H3 demethylase during HSC activation. The overexpression profile of KDM4D was confirmed in three fibrosis animal models and human fibrotic liver tissues. In vitro Kdm4d knockdown impaired the collagen gel contraction and migration capacity of primary HSCs. In established CCl(4)-induced mice model, Kdm4d knockdown inhibited fibrosis progression, and promoted fibrosis reversal, with enhanced thinning and splitting of fibrotic septa, as well as a dramatic decrease in collagen area. Whole gene transcriptome analysis showed the regulatory role of KDM4D in Toll-Like Receptor (TLR) signaling pathway. Mechanistically, KDM4D catalyzed histone 3 on lysine 9 (H3K9) di-, and tri-demethylation, which promoted TLR4 expression, and subsequently prompted liver fibrogenesis by activating NF-κB signaling pathways. INTERPRETATION: KDM4D facilitates TLR4 transcription through demethylation of H3K9, thus activating TLR4/NF-κB signaling pathways in HSCs, contributing to HSC activation and collagen crosslinking, further, hepatic fibrosis progression. FUND: Shanghai New Hundred Talents Program, Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program, Shanghai Key disciplines program of Health and Family Planning and Shanghai Sailing Program. Elsevier 2018-12-06 /pmc/articles/PMC6354657/ /pubmed/30527625 http://dx.doi.org/10.1016/j.ebiom.2018.11.055 Text en © 2018 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research paper
Dong, Fangyuan
Jiang, Shuheng
Li, Jun
Wang, Yahui
Zhu, Lili
Huang, Yiqin
Jiang, Xin
Hu, Xiaona
Zhou, Qi
Zhang, Zhigang
Bao, Zhijun
The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title_full The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title_fullStr The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title_full_unstemmed The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title_short The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
title_sort histone demethylase kdm4d promotes hepatic fibrogenesis by modulating toll-like receptor 4 signaling pathway
topic Research paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354657/
https://www.ncbi.nlm.nih.gov/pubmed/30527625
http://dx.doi.org/10.1016/j.ebiom.2018.11.055
work_keys_str_mv AT dongfangyuan thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT jiangshuheng thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT lijun thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT wangyahui thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhulili thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT huangyiqin thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT jiangxin thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT huxiaona thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhouqi thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhangzhigang thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT baozhijun thehistonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT dongfangyuan histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT jiangshuheng histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT lijun histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT wangyahui histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhulili histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT huangyiqin histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT jiangxin histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT huxiaona histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhouqi histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT zhangzhigang histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway
AT baozhijun histonedemethylasekdm4dpromoteshepaticfibrogenesisbymodulatingtolllikereceptor4signalingpathway